Beyond COVID-19: Antitrust and competition

Canada: Considerations when advertising the health benefits of your products

At the beginning of the COVID-19 pandemic, both Health Canada and the Competition Bureau were quick to issue statements indicating they would continue to monitor the marketplace for false, misleading or deceptive marketing activities related to products claiming they could prevent, treat or cure the virus.

Canada | Publication | April 30, 2020

US: DOJ continues to greenlight coronavirus medical collaborations

The US DOJ again announces it won’t challenge an ongoing collaboration among competitors and government agencies to provide essential COVID-19 healthcare supplies.

United States | Publication | April 23, 2020

Cooperation agreements during the health crisis: European Commission’s guidelines

On April 8, 2020, the European Commission published a communication setting out a temporary framework for analyzing agreements entered into between competitors whose purpose is to address the urgent needs arising from the health crisis (the Temporary Framework).

Global | Publication | April 16, 2020

Belgium: The COVID-19 crisis: EU Competition Policy response

In response to the COVID-19 crisis, European Union (EU) President Ursula von der Leyen has formed a team led by eight Commissioners to coordinate the EU response.

Global | Update | April 15, 2020

An ounce of prevention: Minimizing US antitrust risk when evaluating labor practices

US: An ounce of prevention: Minimizing antitrust risk when evaluating labor practices

COVID-19 has forced many companies to evaluate, and implement cuts to their workforces, reductions in pay, benefits, and hours, or both.

United States | Publication | April 09, 2020

Cooperation amid COVID-19: Medical supply collaboration won’t face US antitrust scrutiny

US: Cooperation amid COVID-19: Medical supply collaboration won’t face antitrust scrutiny

The US DOJ announced in a business review letter its intent not to challenge an ongoing collaboration between numerous healthcare companies

United States | Publication | April 09, 2020

Global: Credit for compliance: Achieving the benefits of a robust antitrust compliance program

COVID-19 (coronavirus) is naturally the focus of everyone’s attention currently given the unprecedented scale of the crisis.

Global | Publication | April 08, 2020

Global: COVID-19: Implications from an antitrust and competition law perspective

The current COVID-19 (coronavirus) crisis sweeping the world is having a hugely disruptive impact on society and business, and our first thoughts and best wishes are with our clients, colleagues and their families who are facing this unprecedented public health challenge.

Global | Update | March 25, 2020

US: Antitrust agencies COVID-19 response: Federal and state authorities warn against price gouging

In the wake of COVID-19, some sellers are greatly increasing the cost of their products.

United States | Publication | March 25, 2020